Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Healthy Extracts (HYEX) Shares Outstanding (Weighted Average) (2016 - 2025)

Healthy Extracts filings provide 11 years of Shares Outstanding (Weighted Average) readings, the most recent being $9.3 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Weighted Average) rose 212.41% to $9.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $9.3 million, a 212.41% increase, with the full-year FY2025 number at $9.3 million, up 212.41% from a year prior.
  • Shares Outstanding (Weighted Average) hit $9.3 million in Q4 2025 for Healthy Extracts, up from $6.8 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $342.5 million in Q3 2022 to a low of $2.9 million in Q4 2022.
  • Median Shares Outstanding (Weighted Average) over the past 5 years was $3.0 million (2025), compared with a mean of $115.5 million.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): tumbled 99.15% in 2023 and later surged 212.41% in 2025.
  • Healthy Extracts' Shares Outstanding (Weighted Average) stood at $319.2 million in 2021, then plummeted by 99.11% to $2.9 million in 2022, then increased by 2.14% to $2.9 million in 2023, then grew by 2.17% to $3.0 million in 2024, then surged by 212.41% to $9.3 million in 2025.
  • The last three reported values for Shares Outstanding (Weighted Average) were $9.3 million (Q4 2025), $6.8 million (Q3 2025), and $3.1 million (Q2 2025) per Business Quant data.